The thrombolytic therapy market covers drug treatment, surgical treatment, etc. The typical players include Roche, Taj Pharmaceuticals, Genentech, etc.
This report aims to provide a comprehensive presentation of the global market for Thrombolytic Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombolytic Therapy. This report contains market size and forecasts of Thrombolytic Therapy in global, including the following market information:
Global Thrombolytic Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Thrombolytic Therapy market was valued at US$ 33450 million in 2022 and is projected to reach US$ 38450 million by 2029, at a CAGR of 2.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global thrombolytic therapy market is dominated by companies from Switzerland, top three players occupy for over 62.78% market share in 2019. Top ten companies occupy 63.45% in the industry.
We surveyed the Thrombolytic Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thrombolytic Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Thrombolytic Therapy Market Segment Percentages, by Type, 2022 (%)
Drug Treatment
Surgical Treatment
Other Treatment
Global Thrombolytic Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Thrombolytic Therapy Market Segment Percentages, by Application, 2022 (%)
Acute Myocardial Infarction
Pulmonary Embolism
Deep Vein Thrombosis
Blocking the Catheter
Acute Ischemic Stroke
Global Thrombolytic Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Thrombolytic Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thrombolytic Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Thrombolytic Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Boehringer Ingelheim
Mochida Pharmaceutical
NanJing Nanda Pharmaceutical
Wanhua Biochem
Tianjin Biochem Pharmaceutical
Livzon Pharmaceutical Group
Sedico Pharmaceuticals
Microbix
Syner-Med
Outline of Major Chapters:
Chapter 1: Introduces the definition of Thrombolytic Therapy, market overview.
Chapter 2: Global Thrombolytic Therapy market size in revenue.
Chapter 3: Detailed analysis of Thrombolytic Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Thrombolytic Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Thrombolytic Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Thrombolytic Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Thrombolytic Therapy Overall Market Size
2.1 Global Thrombolytic Therapy Market Size: 2022 VS 2029
2.2 Global Thrombolytic Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Thrombolytic Therapy Players in Global Market
3.2 Top Global Thrombolytic Therapy Companies Ranked by Revenue
3.3 Global Thrombolytic Therapy Revenue by Companies
3.4 Top 3 and Top 5 Thrombolytic Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Thrombolytic Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thrombolytic Therapy Players in Global Market
3.6.1 List of Global Tier 1 Thrombolytic Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Thrombolytic Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Thrombolytic Therapy Market Size Markets, 2022 & 2029
4.1.2 Drug Treatment
4.1.3 Surgical Treatment
4.1.4 Other Treatment
4.2 By Type - Global Thrombolytic Therapy Revenue & Forecasts
4.2.1 By Type - Global Thrombolytic Therapy Revenue, 2018-2023
4.2.2 By Type - Global Thrombolytic Therapy Revenue, 2024-2029
4.2.3 By Type - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Thrombolytic Therapy Market Size, 2022 & 2029
5.1.2 Acute Myocardial Infarction
5.1.3 Pulmonary Embolism
5.1.4 Deep Vein Thrombosis
5.1.5 Blocking the Catheter
5.1.6 Acute Ischemic Stroke
5.2 By Application - Global Thrombolytic Therapy Revenue & Forecasts
5.2.1 By Application - Global Thrombolytic Therapy Revenue, 2018-2023
5.2.2 By Application - Global Thrombolytic Therapy Revenue, 2024-2029
5.2.3 By Application - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Thrombolytic Therapy Market Size, 2022 & 2029
6.2 By Region - Global Thrombolytic Therapy Revenue & Forecasts
6.2.1 By Region - Global Thrombolytic Therapy Revenue, 2018-2023
6.2.2 By Region - Global Thrombolytic Therapy Revenue, 2024-2029
6.2.3 By Region - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Thrombolytic Therapy Revenue, 2018-2029
6.3.2 US Thrombolytic Therapy Market Size, 2018-2029
6.3.3 Canada Thrombolytic Therapy Market Size, 2018-2029
6.3.4 Mexico Thrombolytic Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Thrombolytic Therapy Revenue, 2018-2029
6.4.2 Germany Thrombolytic Therapy Market Size, 2018-2029
6.4.3 France Thrombolytic Therapy Market Size, 2018-2029
6.4.4 U.K. Thrombolytic Therapy Market Size, 2018-2029
6.4.5 Italy Thrombolytic Therapy Market Size, 2018-2029
6.4.6 Russia Thrombolytic Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Thrombolytic Therapy Market Size, 2018-2029
6.4.8 Benelux Thrombolytic Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Thrombolytic Therapy Revenue, 2018-2029
6.5.2 China Thrombolytic Therapy Market Size, 2018-2029
6.5.3 Japan Thrombolytic Therapy Market Size, 2018-2029
6.5.4 South Korea Thrombolytic Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Thrombolytic Therapy Market Size, 2018-2029
6.5.6 India Thrombolytic Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Thrombolytic Therapy Revenue, 2018-2029
6.6.2 Brazil Thrombolytic Therapy Market Size, 2018-2029
6.6.3 Argentina Thrombolytic Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Thrombolytic Therapy Revenue, 2018-2029
6.7.2 Turkey Thrombolytic Therapy Market Size, 2018-2029
6.7.3 Israel Thrombolytic Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Thrombolytic Therapy Market Size, 2018-2029
6.7.5 UAE Thrombolytic Therapy Market Size, 2018-2029
7 Thrombolytic Therapy Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Thrombolytic Therapy Major Product Offerings
7.1.4 Roche Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Thrombolytic Therapy Major Product Offerings
7.2.4 Boehringer Ingelheim Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Mochida Pharmaceutical
7.3.1 Mochida Pharmaceutical Company Summary
7.3.2 Mochida Pharmaceutical Business Overview
7.3.3 Mochida Pharmaceutical Thrombolytic Therapy Major Product Offerings
7.3.4 Mochida Pharmaceutical Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.3.5 Mochida Pharmaceutical Key News & Latest Developments
7.4 NanJing Nanda Pharmaceutical
7.4.1 NanJing Nanda Pharmaceutical Company Summary
7.4.2 NanJing Nanda Pharmaceutical Business Overview
7.4.3 NanJing Nanda Pharmaceutical Thrombolytic Therapy Major Product Offerings
7.4.4 NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.4.5 NanJing Nanda Pharmaceutical Key News & Latest Developments
7.5 Wanhua Biochem
7.5.1 Wanhua Biochem Company Summary
7.5.2 Wanhua Biochem Business Overview
7.5.3 Wanhua Biochem Thrombolytic Therapy Major Product Offerings
7.5.4 Wanhua Biochem Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.5.5 Wanhua Biochem Key News & Latest Developments
7.6 Tianjin Biochem Pharmaceutical
7.6.1 Tianjin Biochem Pharmaceutical Company Summary
7.6.2 Tianjin Biochem Pharmaceutical Business Overview
7.6.3 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Major Product Offerings
7.6.4 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.6.5 Tianjin Biochem Pharmaceutical Key News & Latest Developments
7.7 Livzon Pharmaceutical Group
7.7.1 Livzon Pharmaceutical Group Company Summary
7.7.2 Livzon Pharmaceutical Group Business Overview
7.7.3 Livzon Pharmaceutical Group Thrombolytic Therapy Major Product Offerings
7.7.4 Livzon Pharmaceutical Group Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.7.5 Livzon Pharmaceutical Group Key News & Latest Developments
7.8 Sedico Pharmaceuticals
7.8.1 Sedico Pharmaceuticals Company Summary
7.8.2 Sedico Pharmaceuticals Business Overview
7.8.3 Sedico Pharmaceuticals Thrombolytic Therapy Major Product Offerings
7.8.4 Sedico Pharmaceuticals Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.8.5 Sedico Pharmaceuticals Key News & Latest Developments
7.9 Microbix
7.9.1 Microbix Company Summary
7.9.2 Microbix Business Overview
7.9.3 Microbix Thrombolytic Therapy Major Product Offerings
7.9.4 Microbix Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.9.5 Microbix Key News & Latest Developments
7.10 Syner-Med
7.10.1 Syner-Med Company Summary
7.10.2 Syner-Med Business Overview
7.10.3 Syner-Med Thrombolytic Therapy Major Product Offerings
7.10.4 Syner-Med Thrombolytic Therapy Revenue in Global Market (2018-2023)
7.10.5 Syner-Med Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Thrombolytic Therapy Market Opportunities & Trends in Global Market
Table 2. Thrombolytic Therapy Market Drivers in Global Market
Table 3. Thrombolytic Therapy Market Restraints in Global Market
Table 4. Key Players of Thrombolytic Therapy in Global Market
Table 5. Top Thrombolytic Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Thrombolytic Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Thrombolytic Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Thrombolytic Therapy Product Type
Table 9. List of Global Tier 1 Thrombolytic Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thrombolytic Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Thrombolytic Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Thrombolytic Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Thrombolytic Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Thrombolytic Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Thrombolytic Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Thrombolytic Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Thrombolytic Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Thrombolytic Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Thrombolytic Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Thrombolytic Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Thrombolytic Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Thrombolytic Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Thrombolytic Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Thrombolytic Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Thrombolytic Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Thrombolytic Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Thrombolytic Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Thrombolytic Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Thrombolytic Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Thrombolytic Therapy Product Offerings
Table 32. Roche Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Boehringer Ingelheim Company Summary
Table 35. Boehringer Ingelheim Thrombolytic Therapy Product Offerings
Table 36. Boehringer Ingelheim Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Boehringer Ingelheim Key News & Latest Developments
Table 38. Mochida Pharmaceutical Company Summary
Table 39. Mochida Pharmaceutical Thrombolytic Therapy Product Offerings
Table 40. Mochida Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Mochida Pharmaceutical Key News & Latest Developments
Table 42. NanJing Nanda Pharmaceutical Company Summary
Table 43. NanJing Nanda Pharmaceutical Thrombolytic Therapy Product Offerings
Table 44. NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. NanJing Nanda Pharmaceutical Key News & Latest Developments
Table 46. Wanhua Biochem Company Summary
Table 47. Wanhua Biochem Thrombolytic Therapy Product Offerings
Table 48. Wanhua Biochem Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Wanhua Biochem Key News & Latest Developments
Table 50. Tianjin Biochem Pharmaceutical Company Summary
Table 51. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Product Offerings
Table 52. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Tianjin Biochem Pharmaceutical Key News & Latest Developments
Table 54. Livzon Pharmaceutical Group Company Summary
Table 55. Livzon Pharmaceutical Group Thrombolytic Therapy Product Offerings
Table 56. Livzon Pharmaceutical Group Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Livzon Pharmaceutical Group Key News & Latest Developments
Table 58. Sedico Pharmaceuticals Company Summary
Table 59. Sedico Pharmaceuticals Thrombolytic Therapy Product Offerings
Table 60. Sedico Pharmaceuticals Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Sedico Pharmaceuticals Key News & Latest Developments
Table 62. Microbix Company Summary
Table 63. Microbix Thrombolytic Therapy Product Offerings
Table 64. Microbix Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Microbix Key News & Latest Developments
Table 66. Syner-Med Company Summary
Table 67. Syner-Med Thrombolytic Therapy Product Offerings
Table 68. Syner-Med Thrombolytic Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Syner-Med Key News & Latest Developments
List of Figures
Figure 1. Thrombolytic Therapy Segment by Type in 2022
Figure 2. Thrombolytic Therapy Segment by Application in 2022
Figure 3. Global Thrombolytic Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Thrombolytic Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Thrombolytic Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thrombolytic Therapy Revenue in 2022
Figure 8. By Type - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Thrombolytic Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Thrombolytic Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 16. US Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 28. China Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Thrombolytic Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Thrombolytic Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Boehringer Ingelheim Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mochida Pharmaceutical Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Wanhua Biochem Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Livzon Pharmaceutical Group Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sedico Pharmaceuticals Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Microbix Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Syner-Med Thrombolytic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
